Extensively drug-resistant TB kills 49% of patients, study finds

11/7/2008 | ABC News

Researchers found that the survival rates of patients with extensively drug-resistant tuberculosis are lower compared with those of patients with multidrug-resistant TB. The finding highlights the importance of administering more aggressive treatment therapies in patients with XDR-TB, the researchers said.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN